PuSH - Publikationsserver des Helmholtz Zentrums München

34 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Kirste, S.* et al.: Combining 68Ga-PSMA-PET/CT-directed and elective radiation therapy improves outcome in oligorecurrent prostate cancer: A retrospective multicenter study. Front. Oncol. 11:640467 (2021)
2.
Orth, M.* et al.: Inhibition of HSP90 as a strategy to radiosensitize glioblastoma: Targeting the DNA damage response and beyond. Front. Oncol. 11:612354 (2021)
3.
Vogel, M.M. et al.: Feasibility and outcome of PSMA-PET-based dose-escalated salvage radiotherapy versus conventional salvage radiotherapy for patients with recurrent prostate cancer. Front. Oncol. 11:715020 (2021)
4.
Volk, V.* et al.: PD-1 blockade aggravates Epstein–Barr Virus+ post-transplant lymphoproliferative disorder in humanized mice resulting in central nervous system involvement and CD4+ T cell dysregulations. Front. Oncol. 10:614876 (2021)
5.
Wang, H.* et al.: A simulated dosimetric study of contribution to radiotherapy accuracy by fractional image guidance protocol of Halcyon system. Front. Oncol. 10:543147 (2021)
6.
Zhao, B.* et al.: AUCseg: An automatically unsupervised clustering toolbox for 3D-segmentation of high-grade gliomas in multi-parametric MR images. Front. Oncol. 11:679952 (2021)
7.
Bergmann, N.* et al.: The intratumoral heterogeneity reflects the intertumoral subtypes of glioblastoma multiforme: A regional immunohistochemistry analysis. Front. Oncol. 10:494 (2020)
8.
Fischbeck, A. et al.: Tumor lactic acidosis: Protecting tumor by inhibiting cytotoxic activity through motility arrest and bioenergetic silencing. Front. Oncol. 10:589434 (2020)
9.
Huang, Y.* et al.: A preliminary simulation study of dose-guided adaptive radiotherapy based on Halcyon MV cone beam CT images with retrospective data from a phase II clinical trial. Front. Oncol. 10:574889 (2020)
10.
Jansen, L.* et al.: Area-based socioeconomic inequalities in colorectal cancer survival in Germany: Investigation based on population-based clinical cancer registration. Front. Oncol. 10:857 (2020)
11.
Wu, F.* et al.: Emerging landscapes of tumor immunity and metabolism. Front. Oncol. 10:575037 (2020)
12.
Bao, X. et al.: Immune landscape of invasive ductal carcinoma tumor microenvironment identifies a prognostic and immunotherapeutically relevant gene signature. Front. Oncol. 9:903 (2019)
13.
Mycielska, M.E.* et al.: Potential use of gluconate in cancer therapy. Front. Oncol. 9:522 (2019)
14.
van Zyl, D.G.* ; Mautner, J. & Delecluse, H.-J.*: Progress in EBV vaccines. Front. Oncol. 9:104 (2019)
15.
Gabryś, H.S.* ; Buettner, F. ; Sterzing, F.* ; Hauswald, H.* & Bangert, M.*: Design and selection of machine learning methods using radiomics and dosiomics for normal tissue complication probability modeling of xerostomia. Front. Oncol. 8:35 (2018)
16.
Kessel, K.A. et al.: Editorial: Data based radiation oncology-design of clinical trials. Front. Oncol. 8:34 (2018)
17.
Schwendner, M.J.* et al.: The role of navigated transcranial magnetic stimulation motor mapping in adjuvant radiotherapy planning in patients with supratentorial brain metastases. Front. Oncol. 8:424 (2018)
18.
Combs, S.E. et al.: Master of Science (MSc) program in radiation biology: An interdepartmental course bridging the gap between radiation-related preclinical and clinical disciplines to prepare next-generation medical scientists. Front. Oncol. 7:226 (2017)
19.
Duma, M.N. et al.: Tangential field radiotherapy for breast cancer-the dose to the heart and heart subvolumes: What structures must be contoured in future clinical trials? Front. Oncol. 7:130 (2017)
20.
Peeken, J.C.* ; Vaupel, P.* & Combs, S.E.: Integrating hyperthermia into modern radiation oncology: What evidence is necessary? Front. Oncol. 7:132 (2017)